炎症性肠病
微生物群
炎症性肠病
生物制品
肠道菌群
医学
肠道微生物群
生物
生物信息学
免疫学
疾病
生态学
病理
生物燃料
作者
Mirae Lee,Eugene B. Chang
标识
DOI:10.1053/j.gastro.2020.09.056
摘要
Inflammatory bowel diseases (IBD) develop via convergence of environmental, microbial, immunological, and genetic factors. Alterations in the gut microbiota have been associated with development and progression of IBD, but it is not clear which populations of microbes are involved or how they might contribute to IBD. We review the genetic and environmental factors affecting the gut microbiota, the roles of gut microbes and their bioproducts in the development and clinical course of IBD, and strategies by which microbiome-based therapies can be used to prevent, manage, and eventually cure IBD. We discuss research findings that help bridge the gap between the basic sciences and clinical application.
科研通智能强力驱动
Strongly Powered by AbleSci AI